Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $167.6000 (0.3%) ($167.6000 - $167.6000) on Fri. Jan. 22, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.94% (three month average) | RSI | 70 | Latest Price | $167.6000(0.3%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR advances 3.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(35%) VYM(30%) VFMO(29%) IBB(27%) VT(27%) | Factors Impacting UTHR price | UTHR will decline at least -0.97% in a week (0% probabilities). VIXM(-22%) VXX(-16%) UUP(-12%) TLT(-3%) BND(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.97% (StdDev 1.94%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $170.08(-1.46%) | 10 Day Moving Average | $167.81(-0.13%) | 20 Day Moving Average | $161.39(3.85%) | To recent high | -3.2% | To recent low | 37.2% | Market Cap | $7.434b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |